Freezing Medium for Cells and Cryopreservation Protocols

Freezing kills cells in two distinct ways, and cryopreservation is a compromise between them.

Intracellular ice. If cooling is fast, water inside the cell has no time to leave before it freezes. Ice crystals form within the cytoplasm, and growing crystals mechanically shred membranes and organelles. This is essentially always lethal.

Solution effects. If cooling is slow, extracellular water freezes first, leaving the remaining unfrozen solution progressively more concentrated. The cell loses water osmotically into that concentrated solution and shrinks, and it is exposed for a prolonged period to very high solute concentrations, extremes of pH and altered ionic strength. This too is damaging.

Between the two lies an optimum cooling rate, and it is cell-type dependent -- a function of how permeable the membrane is to water and how much surface area the cell has relative to its volume. For most mammalian cells that optimum is close to 1 C per minute, which is why that number appears in nearly every protocol.

What a cryoprotectant does. A permeating cryoprotectant such as DMSO or glycerol enters the cell and lowers the freezing point, reduces the fraction of water that turns to ice at any given temperature, and moderates the rise in solute concentration as freezing proceeds. It widens the window between the two lethal mechanisms, so a practical cooling rate becomes survivable. It does not prevent freezing; it changes what freezing does.

Non-permeating cryoprotectants such as trehalose, sucrose and various polymers act outside the cell, controlling extracellular ice structure and dehydrating the cell in a more gradual and controlled way. Modern defined formulations frequently combine both classes.

The classical formulations, all of which remain in wide use:

• 90% fetal bovine serum + 10% DMSO. The traditional choice, and still the most robust for many established adherent lines. Serum proteins provide additional protection against osmotic and mechanical stress during the transitions.
• Complete growth medium + 10% DMSO. Simpler and cheaper, and adequate for many lines. Post-thaw recovery is often slightly lower than with high-serum formulations.
• 50% complete medium + 40% FBS + 10% DMSO. A common middle ground.
• Conditioned medium plus fresh medium plus DMSO, used for insect and some suspension cells, where cell-conditioned medium improves recovery.

DMSO concentration: 5-10%. Ten percent is the standard starting point and works for the majority of mammalian cell lines. Five percent is often equally effective and less toxic, and is worth testing for any line you freeze routinely -- particularly sensitive primary cells, stem cells and cells that will be thawed directly into a sensitive assay. Concentrations above 10% are rarely beneficial and increase toxicity. Concentrations below about 5% generally give poor protection for mammalian cells.

Glycerol is used at 5-10% as an alternative permeating cryoprotectant. It penetrates cells more slowly than DMSO, so it requires a longer equilibration, but it is less toxic at room temperature and does not carry DMSO's differentiation-inducing effects. It is the standard cryoprotectant for bacteria and yeast, and it is a genuine option for mammalian cells that respond poorly to DMSO. It is not a drop-in substitute -- test it before switching a valuable line.

Cell density. Freeze at 1 x 10^6 to 1 x 10^7 cells/mL, with 1-5 x 10^6 cells/mL typical for routine lines. Freezing too sparsely gives poor recovery, since cells recover better from a reasonably dense inoculum. A standard vial holds 1-1.8 mL.

Quality of the starting culture matters more than the formulation. Cells should be in log-phase growth, healthy, and at above 90% viability before freezing. A culture that is confluent, overgrown, recently stressed or already declining will freeze badly no matter what medium you use. This is the single largest determinant of post-thaw recovery and the one most often neglected.

Prepare freezing medium fresh and keep it cold. DMSO generates heat on mixing with aqueous solutions, so prepare in advance and chill to 2-8 C before adding cells.

Work quickly once DMSO is added -- it is toxic to cells at temperatures above freezing, and contact time at room temperature should be minimised.

Preparation

1. Prepare freezing medium in advance and chill to 2-8 C. Label cryovials with cell line, passage number, date, cell number and operator before you start; writing on frosted vials afterwards is unreliable.
2. Confirm the culture is healthy and in log phase, not confluent, and above 90% viability by trypan blue count.

Harvest

3. Harvest adherent cells with trypsin-EDTA, using the minimum digestion needed, and neutralise promptly. Over-trypsinised cells freeze poorly.
4. Centrifuge gently -- typically 200-300 x g for 5 minutes -- and remove the supernatant completely.
5. Count and determine viability. Record the pre-freeze count; you will want it when interpreting post-thaw recovery.

Resuspend and fill

6. Resuspend the pellet in cold freezing medium at 1-5 x 10^6 cells/mL. Resuspend gently and completely, avoiding bubbles.
7. Dispense 1-1.8 mL per cryovial, mixing the suspension periodically so that later vials contain the same density as earlier ones. Cells settle quickly.
8. Some protocols allow a short equilibration of about 10-15 minutes to let DMSO permeate; others move straight to cooling. Either is defensible, but do not leave cells in DMSO at room temperature for extended periods.

Cool at a controlled rate

9. Transfer vials to a controlled-rate cooling container -- an isopropanol-jacketed or engineered passive cooler -- and place in a -80 C freezer. These deliver approximately -1 C per minute, which suits most mammalian cells.
10. Leave overnight, or a minimum of about 4 hours.
11. For high-value material, cell therapy work or cells with unusual optimal rates, use a programmable controlled-rate freezer, which gives a reproducible, documented profile and can apply a controlled ice nucleation step.

Transfer to long-term storage

12. Move vials to liquid nitrogen vapour phase promptly -- within 24-72 hours. Do not leave them in the -80 C freezer as long-term storage.
13. Record the exact location in your inventory at the moment of transfer.

Verify

14. Thaw one vial after 24-48 hours and check viability and recovery. A bank that has never been tested is not a bank. Do this before discarding the parent culture.

Long-term storage requires temperatures below approximately -135 C. This is the glass transition temperature of the residual aqueous phase. Above it, water molecules retain enough mobility for ice to slowly recrystallise -- small crystals merge into larger ones over time, and the growing crystals damage cells. Below it, the solution is effectively a glass and molecular motion essentially stops, so cells can be stored indefinitely.

A -80 C freezer is above that threshold. Cells stored at -80 C lose viability progressively -- usually tolerable over weeks to a few months, and unreliable beyond that. Using -80 C as long-term storage is a common and expensive mistake: the loss is silent and only discovered when an irreplaceable vial fails to recover years later.

Liquid nitrogen storage provides -196 C in the liquid phase and typically -150 C to -190 C in the vapour phase, both comfortably below the threshold.

Vapour phase is preferred over liquid phase, for two reasons. First, liquid nitrogen can seep into imperfectly sealed cryovials; on warming, the trapped nitrogen expands violently and vials can burst, which is a genuine injury risk when removing a rack. Second, liquid nitrogen can transfer contamination between vials, and documented incidents of cross-contamination in liquid-phase storage exist. Vapour phase avoids both. If you do use liquid phase, use vials rated for it or over-wrap them.

Practical storage discipline:

• Split the bank across two vessels, ideally in different rooms or on different alarm circuits. A single freezer failure should never be able to destroy a line.
• Monitor and alarm nitrogen level and temperature, with an out-of-hours escalation path that a real person answers.
• Keep a written inventory that is independent of any single computer, and update it at the time of deposit rather than later.
• Minimise time out of storage. Work quickly when retrieving vials and keep racks below the neck of the vessel. Repeated brief warming of neighbouring vials degrades them.
• Wear a face shield and cryogenic gloves when handling stored vials.
• Bank in two tiers -- a master bank at low passage that is rarely touched, and a working bank drawn from it for routine use.

Thawing inverts the logic of freezing: cool slowly, thaw fast. Slow warming allows small ice crystals to recrystallise into large damaging ones, so speed through the transition is protective.

1. Prepare before you retrieve the vial. Pre-warm complete growth medium to 37 C and have a labelled flask or tube ready. The vial should be out of storage for as little time as possible.
2. Retrieve wearing a face shield and cryogenic gloves. Transport in a small container of dry ice or liquid nitrogen if the walk is more than a few seconds.
3. Thaw rapidly in a 37 C water bath, 1-2 minutes, agitating gently. Keep the cap above the water line to avoid contaminating the threads. Stop while a small ice crystal remains -- do not warm the vial to 37 C. A fully thawed vial sitting in the bath is cells sitting in DMSO at 37 C, which is exactly what you are trying to avoid.
4. Decontaminate the outside of the vial with 70% ethanol before opening in the cabinet.
5. Dilute slowly. Transfer the contents to a tube and add pre-warmed medium dropwise at first, then more quickly, to roughly ten times the vial volume. Adding medium fast causes osmotic shock: the cell is loaded with DMSO, and sudden dilution of the external solution drives water in rapidly. This step is the most common cause of poor recovery from a properly frozen vial.
6. Remove the DMSO. Either centrifuge gently at 200-300 x g for 5 minutes and resuspend in fresh medium, or -- for shear-sensitive cells -- seed directly into a larger volume and change the medium after 4-24 hours once cells have attached. Both are acceptable; the centrifugation route removes DMSO faster, the direct-seeding route avoids a centrifugation step on fragile cells.
7. Seed at a generous density. Post-thaw cultures recover better when dense. Do not split a freshly thawed vial across several flasks.
8. Assess. Check attachment and morphology at 24 hours. Expect above 80-90% post-thaw viability from a well-prepared bank of an established line, though primary and sensitive cells are often lower.
9. Allow the culture to recover before use. Give cells at least two or three passages to return to normal doubling time and morphology before using them for an experiment. Cells straight off a thaw are not physiologically normal, and results generated on them are frequently irreproducible.

The classical 90% FBS plus 10% DMSO formulation carries both of the ingredients that modern cell culture is trying to move away from.

Serum-free and animal-origin-free freezing media. If a line has been adapted to serum-free growth, freezing it in 90% serum is incoherent -- it reintroduces the material you removed, imposes a serum exposure at every bank-and-thaw cycle, and reintroduces lot variation into the recovery step. Defined serum-free freezing media are mature, widely available and perform comparably to serum-based formulations for most adapted lines. For any process moving toward manufacture, an animal-origin-free freezing medium is effectively required, since a bovine-derived component in the cell bank is a regulatory and adventitious-agent issue regardless of what the production medium contains.

High-density formulations exist for banking at elevated cell concentrations, which matters when a single vial must seed a large culture or when storage space is constrained.

Reducing or removing DMSO. DMSO has real drawbacks beyond its acute toxicity:

• It induces differentiation in some cell lines -- a well-documented effect that is exploited deliberately in some systems and is an unwanted confounder in others.
• It has documented effects on gene expression and epigenetic marks, which is a concern for stem cells and for any work where the epigenetic state is the subject.
• In cell therapy manufacturing, there is sustained interest in reducing or eliminating DMSO from the final product, and reducing it lowers the burden on downstream washing steps.

DMSO-free chemically defined cryopreservation solutions are commercially available and typically combine non-permeating sugars such as trehalose or sucrose with polymers and other protective agents, sometimes with a low-toxicity permeating agent. Performance is cell-type dependent: some lines freeze in them as well as in DMSO, others recover measurably less well. They are a genuine option rather than a universal replacement, and the correct approach is to test them on your own line in parallel with your existing method before committing a bank.

How to evaluate any new freezing medium:

1. Freeze matched vials in the current formulation and the candidate, from the same harvest, at the same density and by the same cooling profile.
2. Store both for a meaningful interval -- at least a week, preferably longer, since some differences only appear after extended storage.
3. Thaw in parallel and compare immediate post-thaw viability, attachment at 24 hours, time to return to normal doubling, and the functional endpoint your work depends on.
4. Only then convert the bank, and keep vials of the old formulation until the new one has proven itself over a full cycle.